News
IQV
194.23
+0.41%
0.79
Earnings To Watch: Charles River Laboratories (CRL) Reports Q4 Results Tomorrow
Barchart · 7h ago
Parnassus Mid Cap Fund Q4 And 2024 Annual Investment Commentary
Seeking Alpha · 1d ago
J.P. Morgan Remains a Buy on IQVIA Holdings (IQV)
TipRanks · 1d ago
Weekly Report: what happened at IQV last week (0210-0214)?
Weekly Report · 1d ago
IQVIA: Revenues, Net Profit Margin, And A Positive Long-Term Outlook Will Pave The Way
Seeking Alpha · 2d ago
IXJ: Healthcare Sector Dashboard For February
Seeking Alpha · 2d ago
Nvidia Could Power Up This Under-the-Radar Healthcare Stock
Barchart · 2d ago
Earnings growth of 2.5% over 1 year hasn't been enough to translate into positive returns for IQVIA Holdings (NYSE:IQV) shareholders
Simply Wall St · 3d ago
IQVIA HOLDINGS INC. FORM 10-K
Press release · 4d ago
West Pharmaceutical Services (WST) Q4 Earnings Report Preview: What To Look For
Barchart · 6d ago
IQVIA Holdings Price Target Raised to $250.00/Share From $245.00 by Morgan Stanley
Dow Jones · 6d ago
IQVIA Holdings Is Maintained at Overweight by Morgan Stanley
Dow Jones · 6d ago
Morgan Stanley Maintains Overweight on IQVIA Hldgs, Raises Price Target to $250
Benzinga · 6d ago
S&P Global Q4 Earnings & Revenues Surpass Estimates, Increase Y/Y
Barchart · 02/11 12:08
Cedar Creek Partners 2024 Results
Seeking Alpha · 02/11 10:10
Analysts Offer Insights on Healthcare Companies: Cytokinetics (CYTK), Insmed (INSM) and IQVIA Holdings (IQV)
TipRanks · 02/11 07:00
Top Research Reports for Procter & Gamble, Boston Scientific & ConocoPhillips
NASDAQ · 02/10 21:51
IQVIA Holdings Price Target Maintained With a $270.00/Share by RBC Capital
Dow Jones · 02/10 16:37
RBC Capital Reiterates Outperform on IQVIA Hldgs, Maintains $270 Price Target
Benzinga · 02/10 16:26
IQVIA Holdings Price Target Raised to $263.00/Share From $261.00 by Truist Securities
Dow Jones · 02/10 14:19
More
Webull provides a variety of real-time IQV stock news. You can receive the latest news about Iqvia Hldgs Inc through multiple platforms. This information may help you make smarter investment decisions.
About IQV
IQVIA Holdings Inc. is a provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. Its segments include Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. Technology & Analytics Solutions segment offers mission-critical information, technology solutions and real-world insights and services to its life science clients. Research & Development Solutions segment serves biopharmaceutical customers and provides outsourced clinical research and clinical trial related services. Contract Sales & Medical Solutions segment offers health care providers (including contract sales) and patient engagement services to both biopharmaceutical clients and the broader healthcare market. Its Connected Intelligence delivers insights and solutions enabling customers to accelerate the clinical development and commercialization of medical treatments that improve healthcare outcomes for patients.